November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Dégi László Csaba: A bittersweet moment as we bid farewell to Mike Morrissey
Nov 24, 2024, 16:12

Dégi László Csaba: A bittersweet moment as we bid farewell to Mike Morrissey

Dégi László Csaba, The President of the European Cancer Organisation, posted on LinkedIn:

“A bittersweet moment as we bid farewell to Mike Morrissey, our extraordinary Chief Executive at European Cancer Organisation. At the European Cancer Summit 2024, I shared these personal words:

‘Mike, I don’t know if you remember this, but we met on a bus returning from a conference dinner. I wouldn’t say it was the most professional circumstances that we met, but it turned out to be one of the great collaborations in my career and lifetime. You’re a people maker – I’ve always said this to you. You have rebuilt this organization and become the face of cancer policy in Europe.
I am more than grateful for these five years, though it’s not easy to say goodbye. I’ll always remember that beautiful sunny day in Barcelona, at another conference, discussing shared decision-making. The joy and the pain I felt there – I told you I would never forget that garden and that moment. I hope you will never forget us. Thank you is the least I can say. Thank you very much, Michael.’

Under Mike’s leadership, ECO has transformed and strengthened its position in European cancer policy. His legacy will continue to shape our future.”

Dégi László Csaba: A bittersweet moment as we bid farewell to Mike Morrissey Dégi László Csaba: A bittersweet moment as we bid farewell to Mike Morrissey

Dr. Dégi László Csaba serves as the President of the European Cancer Organisation and is a member of the Board of Directors for the Organisation of European Cancer Institutes (OECI). He is also an expert for the CCI4EU project and a board member for Diversity, Inclusion, and Belonging at COM’ON CLUJ NEXT. Additionally, Dr. Csaba is a full-time IPOS Secretary and Executive Officer, as well as a board member for the International Psycho-Oncology Society (IPOS). He is also involved with the Journal of Psychosocial Oncology Research and Practice.